Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01862133 · ClinicalTrials.gov registry record

Aspiring to Awesome- Patient Preference Privacy Selections in EMR

A clinical trial, sponsored by Indiana University.

Completed
Registry status
136
Enrollment target

NCT01862133: Completed study, sponsored by Indiana University.

NCT01862133 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01862133 has completed, sponsored by Indiana University.

COMPLETED
Registry status
136 participants
Enrollment target

Study Summary

Health information technology, including health information exchange, offers the potential to improve care by providing an integrated view of relevant, integrated patient information from multiple health care providers practicing in multiple sites. However, realizing that potential can be difficult, particularly with respect sensitive information. Increasingly, patients, patient advocate groups, and even the National Coordinator for Health Information Technology are pushing for patients to have more granular control over specifically who can see what personal health information in their electronic health records. This will be a demonstration project aimed at showing the initial feasibility a system allowing patient controls on their electronic health records. Because of the exploratory nature of the research, the investigators do not have specific hypotheses. The investigators hope that this demonstration and feasibility project will lead to more extensive prospective evaluations of patient control of access to their health records and other tools for enhancing patient control over access to their health records.

Primary Outcome

Patients had to restrict access to either all data or one of five categories of "sensitive" data (sexually transmitted infections, HIV/AIDS, sexual health and pregnancy, drug and alcohol use and abuse, and mental health information) to one or more of the study providers.

Interventions

  • OTHER Patient preferences

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2013-08
Est. Completion 2014-03
Indiana University

890 total trials

What the finished NCT01862133 record still lists

NCT01862133 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Patient preferences is the first listed.

NCT01862133 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01862133 about?

NCT01862133 is a clinical study titled "Aspiring to Awesome- Patient Preference Privacy Selections in EMR". Health information technology, including health information exchange, offers the potential to improve care by providing an integrated view of relevant, integrated patient information from multiple health care providers practicing in multiple sites. However, realizing that potential can be difficult,...

What is the current status of trial NCT01862133?

This trial is currently completed. The enrollment target is 136 participants. The study started on 2013-08. Estimated completion is 2014-03.

What interventions are being tested in trial NCT01862133?

The interventions under investigation include: Patient preferences (OTHER).

Who is sponsoring clinical trial NCT01862133?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01862133, the US trial registry maintained by the National Library of Medicine. NCT01862133 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.